ClinicalTrials.Veeva

Menu

DD T2 Daily Disposable Registration Trial

Alcon logo

Alcon

Status

Completed

Conditions

Myopia
Refractive Errors

Treatments

Device: delefilcon A contact lenses
Device: verofilcon A contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT03305770
CLE383-C005

Details and patient eligibility

About

The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity as the primary variable.

Full description

Enrolled participants will be randomized (2:1) to receive either verofilcon A (test) contact lenses or delefilcon A (control) contact lenses for wear in both eyes and attend 7 office visits: Baseline, Dispense, 1-week follow-up, 2-week follow-up, 1-month follow-up, 2-month follow-up and 3-month follow-up/Exit.

Enrollment

107 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Successful wear of spherical soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day.
  • Best corrected VA 20/25 or better in each eye.
  • Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

  • Any current or prior wear experience with DT1 lenses.
  • Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
  • Other protocol-specified exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

107 participants in 2 patient groups

DD T2
Experimental group
Description:
Verofilcon A contact lenses worn in both eyes for 3 months in a daily wear, daily disposable modality. A new pair of study lenses will be inserted each day and discarded at the end of the day.
Treatment:
Device: verofilcon A contact lenses
DT 1
Active Comparator group
Description:
Delefilcon A contact lenses worn in both eyes for 3 months in a daily wear, daily disposable modality. A new pair of study lenses will be inserted each day and discarded at the end of the day.
Treatment:
Device: delefilcon A contact lenses

Trial documents
2

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems